Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

Clinical trial NCT05554419 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05554419
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia Arising From Previous Myeloproliferative Neoplasm Acute Myeloid Leukemia Post Cytotoxic Therapy Secondary Acute Myeloid Leukemia

Start date: 2026-07-01
Primary completion: 2026-08-31
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.